Founded by exited entrepreneurs, Science Creates is a Deep Tech ecosystem that enables scientists and engineers to turn their groundbreaking discoveries into disruptive businesses that can revolutionise the health of people and the planet.
By backing founders, we're building capability in the critical technologies — from engineering biology to quantum — that drive economic growth and create the high-skilled jobs of the next decade.
We support our startup community with specialised lab space, expert training and mentoring, a network of partner organisations, and access to investment opportunities. Through our independent charity and public events, we inspire the next generation of scientists and entrepreneurs.




.webp)

Our ethos
We believe the next big breakthroughs will emerge at the intersection of fields like quantum, AI, and biotechnology — and that spinouts are the most powerful way to turn those innovations into global impact.
The first step is empowering those at the forefront of knowledge with the right infrastructure, training, resources and investment.
Science Creates is laying the foundations for bold ideas and innovation to thrive and scale, nationwide.
Designed for flexibility, OMX, our new 30,000 sq ft of lab, office, and meeting space for startups and scaleups is now ready to take new tenants.
We currently welcome applications from service providers working in legal, IT, grants, cloud, bespoke software and marketing.
We invest in Deep Tech at the pre-seed and seed stages — and our endgame is global impact.



Our focus
Deep Tech refers to innovations based on major breakthroughs in science and engineering, often built on years of research and proprietary technology to solve global challenges. Unlike regular tech, it focuses on transformative, long-term solutions in fields like AI, quantum, engineering biology and advanced materials — the UK government's designated frontier industries.
Deep Tech can revolutionise entire industries, create high-skilled jobs and unlock new economic growth while improving lives.
We specialise in Deep Tech because the social, environmental and economic returns are proportional to the ambition. It demands patient capital and deep technical understanding, and that's exactly what we're built to provide.

Pictura Bio is creating a rapid pathogen detection platform to scale diagnostics for infectious diseases at the point of care. Combining the power of single-molecule fluorescent microscopy with machine learning and optical engineering, its patented technology is able to identify an array of pathogens in under a minute. This enables faster, affordable and universally accessible diagnostics to accurately determine the causes of infections.

Scarlet Therapeutics is developing a proprietary platform that generates novel red blood cell-based therapeutics (tRBCs) to treat a wide range of diseases. Its technologies are underpinned by learnings from decades of research including the groundbreaking RESTORE clinical study run by NHS Blood and Transplant and the University of Bristol, investigating transfusion of lab-grown blood into patients. By generating tRBCs with high levels of therapeutic proteins from cell lines rather than from donated stem cells, Scarlet Therapeutics aims to address significant efficacy and manufacturing issues faced in the field.

Celltris is reimagining battery cell design to unlock fast charging for heavy electric vehicles. Its mechanical approach to cell terminal design enables battery packs to be built at a 40% reduction in component costs with a 60% cut in heat generation. This enables industrial vehicles to be charged 2-3x faster without the thermal penalty, removing the need for oversized cooling systems or bottlenecks from slow charge times.



Our versatile spaces can welcome a variety of events, from small meetings to 60-person seminars including catering and a fully licensed bar.
